Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA's Consumer Ad Watchdogs

This article was originally published in RPM Report

Executive Summary

FDA monitors and controls pharma's product messages to consumers with a remarkably small staff. Seven people are involved directly in keeping track of the 15,000 consumer promotional pieces and about 500 broadcast ads that FDA receives annually.

You may also be interested in...



The New Era in DTC: FDA Plans New Fees, Fines-and Creative Advice

The new FDA law marks a turning point in the relatively short history of direct-to-consumer broadcast ads. Sponsors have preserved the right to advertise, but will have to get used to following FDA's schedule-and taking FDA's advice.

The New Era in DTC: FDA Plans New Fees, Fines-and Creative Advice

The new FDA law marks a turning point in the relatively short history of direct-to-consumer broadcast ads. Sponsors have preserved the right to advertise, but will have to get used to following FDA's schedule-and taking FDA's advice.

PhRMA's Senior Management Team: Industry Experience with Cajun Seasoning

The people behind the new Pharmaceutical Research & Manufacturers of America under former House Energy & Commerce Committee Chairman Billy Tauzin, and the appointees on PhRMA's independent direct-to-consumer advertising review panel.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS080052

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel